Methods and compositions for the treatment of hair loss

1. A method of treating hair loss in a patient suffering therefrom comprising applying a formulation to an area of hair loss wherein the active agents of the formulation consist of latanoprost and minoxidil.

2. The method of claim 1 wherein the active agents consist of 0.01-0.2% w/v latanoprost and 2-7% w/v minoxidil.

3. The method of claim 2 wherein the active agents consist of 0.04-0.1% w/v latanoprost and 2-5% w/v minoxidil.

4. The method of claim 1 wherein the patient is suffering from one selected from the group consisting of androgenetic alopecia, alopecia areata, alopecia totalis and alopecia universalis.

5. The method of claim 1 wherein the formulation is applied topically to the skin of the area of hair loss.

6. The method of claim 3 wherein application of the formulation to the area of hair loss grows hair to a greater extent than the same formulation with the same amount and concentration of latanoprost but without minoxidil applied to the same area.

7. The method of claim 3 wherein application of the formulation grows hair to a greater extent than the same formulation with the same amount and concentration of minoxidil but without latanoprost applied to the same area.

8. The method of treating hair loss of claim 3 wherein the patient experiences hair growth to a greater extent as compared to if the patient had not applied formulation.

9. The method of claim 5 wherein the area of hair loss is the scalp.

10. The method of claim 3 wherein the formulation is applied at least once a day to the scalp.

11. A method of treating androgenetic alopecia in a patient suffering therefrom comprising applying a formulation to an area experiencing hair loss wherein the active agents of the formulation consist of latanoprost and minoxidil.

12. The method of claim 11 wherein the active agents consist of 0.01-0.2% w/v latanoprost and 2-7% w/v minoxidil.

13. The method of claim 12 wherein the active agents consist of 0.04-0.1% w/v latanoprost and 2-5% w/v minoxidil.

14. The method of claim 13 wherein the patient experiences more hair growth in the area experiencing hair loss where the formulation is applied as compared to if the patient had not applied the formulation to the area experiencing hair loss.

15. The method of claim 13 wherein new hair growth results in the area experiencing hair loss where the formulation is applied which is darker as compared to hair growth in areas where the patient did not apply the formulation.

16. The method of claim 13 wherein new hair growth results in the area experiencing hair loss where the formulation is applied in which the individual hairs are thicker in diameter as compared to hair growth in areas where the patient did not apply the formulation.

17. The method of claim 13 wherein new hair growth results in the area experiencing hair loss where the formulation is applied in which the individual hairs have a greater melanin concentration as compared to hair growth in areas where the patient did not apply the formulation.

18. The method of claim 13 wherein the formulation is applied to one selected from the group consisting of the scalp, the skin beneath the eyebrows, upper eyelid margin, lower eyelid margin and the face.

19. The method of claim 13 wherein the application of the formulation to an area experiencing hair loss grows hair to a greater extent than the same amount of minoxidil applied at the same concentration but without latanoprost to the same area.

20. The method of claim 13 wherein the application of the formulation to the scalp results in a faster onset of new hair growth as compared to the patient not applying the formulation.